The Cooper Companies, Inc. $COO Holdings Increased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 0.7% in the second quarter, HoldingsChannel reports. The fund owned 2,549,015 shares of the medical device company’s stock after purchasing an additional 18,946 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Cooper Companies were worth $182,790,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Avalon Trust Co acquired a new position in shares of Cooper Companies during the second quarter valued at approximately $25,000. Root Financial Partners LLC lifted its position in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the period. SJS Investment Consulting Inc. boosted its stake in Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares in the last quarter. Elevation Wealth Partners LLC boosted its stake in Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp acquired a new position in shares of Cooper Companies during the 2nd quarter valued at $32,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Down 1.2%

Shares of Cooper Companies stock opened at $69.28 on Wednesday. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The firm has a market capitalization of $13.51 billion, a PE ratio of 58.71, a price-to-earnings-growth ratio of 1.83 and a beta of 0.82. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The stock’s fifty day moving average is $72.72 and its 200-day moving average is $70.63.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter last year, the company posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Needham & Company LLC dropped their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a research report on Wednesday, May 27th. Finally, Citigroup reaffirmed a “neutral” rating and issued a $80.00 price objective (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $81.64.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.